Figure 1.

A: Kaplan-Meier plot of patients who meet the RIFLE criteria by treatment with intravenous voriconazole (____), caspofungin (_ _ _ _), and fluconazole (. . . . .). B: Kaplan-Meier plot of patients who meet the RIFLE criteria by formulations containing SBECD (____) and those with formulations which do not contain SBECD (_ _ _ _).

Lilly et al. BMC Infectious Diseases 2013 13:14   doi:10.1186/1471-2334-13-14
Download authors' original image